Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Interventional × Hyperparathyroidism × Clear all

Phase

Phase NA 6 Phase 4 2 Phase 2 2 Phase 1 2 Phase EARLY_PHASE1 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 986 Carcinoma, Non-Small-Cell Lung 621 Neoplasms 486 Prostatic Neoplasms 444 Colorectal Neoplasms 379 Multiple Myeloma 294 Lung Neoplasms 267 Neoplasm Metastasis 258 Leukemia, Myeloid, Acute 233 Carcinoma, Hepatocellular 224 Stomach Neoplasms 220 Ovarian Neoplasms 193 Rectal Neoplasms 185 Lymphoma 177 Lymphoma, Follicular 176 Colonic Neoplasms 176 Leukemia 164 Uterine Cervical Neoplasms 157 Pancreatic Neoplasms 155 Lymphoma, Non-Hodgkin 150 Head and Neck Neoplasms 150 Recurrence 144 Lymphoma, Large B-Cell, Diffuse 143 Leukemia, Lymphocytic, Chronic, B-Cell 141 Precursor Cell Lymphoblastic Leukemia-Lymphoma 139 Melanoma 137 Brain Neoplasms 127 Urinary Bladder Neoplasms 124 Pain 124 Squamous Cell Carcinoma of Head and Neck 123

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04040946 2023-08-01

APACH2

Centre Francois Baclesse

Phase 3 Completed

Hyperparathyroidism, Parathyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡